The effect of surveillance for symptomatic toxicities with real-time clinician reporting on dose reduction, hospitalization and febrile neutropenia in Danish breast cancer patients—a population-based cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)